Cambridge, United Kingdom

Martin Edward Fox

USPTO Granted Patents = 6 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Cambridge, GB (2000 - 2001)
  • Histon, GB (2005)

Company Filing History:


Years Active: 2000-2005

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Martin Edward Fox

Introduction

Martin Edward Fox, a distinguished inventor based in Cambridge, GB, has made significant contributions to the field of pharmaceuticals with his innovative inventions. With a total of six patents to his name, Fox has played a pivotal role in advancing chemical processes related to therapeutic compounds.

Latest Patents

Among his latest innovations, one notable patent is the "Process for the preparation of 11-oxaprostaglandins and intermediates therein". This patent describes a novel method for synthesizing compounds such as [2R,(1E,3R),3S,(4Z),4R)]-7-{tetrahydro-2-[4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-4-hydroxy-3-furanyl}-4-heptenoic acid and its ester derivatives. The method utilizes an enantiomerically enriched compound, showcasing flexibility in the bonding arrangements between carbon atoms, ultimately broadening the scope of possible derivatives. Another key patent is the "Process for the preparation of calanolide precursors," which discusses innovative compounds designed for therapeutic applications.

Career Highlights

Throughout his career, Martin Fox has been affiliated with notable companies such as Chirotech Technology Limited and Medeva Europe Limited. His work within these organizations has not only highlighted his expertise in pharmaceutical chemistry but has also contributed to the overall advancement of the industry.

Collaborations

In his journey as an inventor, Fox has collaborated with esteemed colleagues, including Julian Simon Parratt and Jane Marie Paul. These partnerships have likely fostered an environment of innovation and creativity, leading to the patents and technologies that mark his career.

Conclusion

Martin Edward Fox's commitment to innovation in pharmaceutical processes has led to the development of several important patents. His work continues to impact the field significantly, underlining the importance of collaboration and creative thinking in advancements in therapeutic chemistry. His achievements exemplify the spirit of innovation that drives the industry forward.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…